Citations in impact factor journals
Haplotype analysis of XRCC1 (at codons 194 and 399) and breast cancer risk, a case–control study Comparative Clinical Pathology |
Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures Breast Cancer Research and Treatment Vol. 115, Issue 1, 137, 2009 |
Additive effects of genetic variations of xenobiotic detoxification enzymes and DNA repair gene XRCC1 on the susceptibility to breast cancer Breast Cancer Research and Treatment Vol. 120, Issue 1, 263, 2010 |
Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer, a meta-analysis of the literatures Breast Cancer Research and Treatment |
Citation to this article as recorded by
Saadat, M., 2007. GSTM1 null genotype associated with age-standardized cancer mortality rate in 45 countries from five continents: An ecologic study. Int. J. Cancer Res., 3: 74-91. CrossRefDirect Link |
Citation to this article as recorded by
Population Differences in Major Functional Polymorphisms of
Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans:
Implications in the Clinical Trials for Novel Drug Development Drug Metabolism and Pharmacokinetics Vol. 27, Issue 1, 9, 2012 |
GSTM1 Null Genotype Associated with Age-standardized Cancer Mortality Rate in 45 Countries from Five Continents: An Ecologic Study International Journal of Cancer Research Vol. 3, Issue 2, 74, 2007 |
How to cite this article
Leila Kohan, Shahpour Omidvari and Mostafa Saadat, 2006. Combination of XRCC1, GSTM1 and GSTT1 Genetic Polymorphisms and Susceptibility to Male Breast Cancer. International Journal of Cancer Research, 2: 415-419.
DOI: 10.3923/ijcr.2006.415.419
URL: https://scialert.net/abstract/?doi=ijcr.2006.415.419
DOI: 10.3923/ijcr.2006.415.419
URL: https://scialert.net/abstract/?doi=ijcr.2006.415.419